BioCentury
ARTICLE | Financial News

Enumeral raises $21.5M, reverse-merges

August 5, 2014 1:57 AM UTC

Enumeral Biomedical Holdings Inc. (OTCQB:ENUM) reverse-merged with shell company Cerulean Group Inc. and began trading on the OTCQB. The immunotherapy company also raised $21.5 million through the sale of 21.5 million units at $1 in a private placement. Each unit comprises a share of common stock and a five-year warrant to purchase a share at $2. Montrose Capital Partner led the offering. EDI Financial was lead placement agent and Intuitive Venture Partners was financial advisor. ...